Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Stomatin ELISA Kit (AC3771)
Cat.#: ASET-2360
Specifications
Description Human Stomatin ELISA Kit allows for the in vitro quantitative determination of human Stomatin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1094 Human NEUROD4 ELISA Kit (AC2505) Quantitative inquiry ASET-1837 Mouse Nogo ELISA Kit (AC3248) Quantitative inquiry ASET-1011 Rat PTN ELISA Kit (AC2422) Quantitative inquiry ASET-1331 Rat Glutamate Receptor 1 (AMPA subtype) ELISA Kit (AC2742) Quantitative inquiry ASET-2434 Human GAB2 ELISA Kit (AC3845) Quantitative inquiry ASET-2303 Human DCC ELISA Kit (AC3714) Quantitative inquiry ASET-1320 Porcine Myelin Basic Protein ELISA Kit (AC2731) Quantitative inquiry ASET-1577 Mouse Noradrenaline Transporter ELISA Kit (AC2988) Quantitative inquiry ASET-2350 Human P2Y12 ELISA Kit (AC3761) Quantitative inquiry ASET-1507 Human Jagged1 ELISA Kit (AC2918) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket